Error-prone bypass patch by a low-fidelity variant of DNA polymerase zeta in human cells
Error-prone bypass patch by a low-fidelity variant of DNA polymerase zeta in human cells
复制标题
DOI:
10.1016/j.dnarep.2021.103052
复制
发表时间:
2021-02-17
期刊:
影响因子:
3.8
通讯作者:
Nohmi, Takehiko
中科院分区:
文献类型:
--
作者:
Suzuki, Tetsuya;Sassa, Akira;Nohmi, Takehiko
DNA polymerase zeta (Pol zeta) is a specialized Pol that is involved in translesion DNA synthesis (TLS), in particular, in the extension of primer DNA after bypassing DNA lesions. Previously, we established human cells that express a variant form of Pol zeta with an amino acid change of leucine 2618 to methionine (L2618M) in the catalytic subunit REV3L (DNA Repair, 45, 34-43, 2016). This amino acid change made the cells more sensitive to the mutagenicity of benzo [a] pyrene diol epoxide (BPDE). In this study, we embedded BPDE-N-2 -guanine at a defined position in the supF gene on the shuttle plasmid and introduced it to REV3 L2618M cells or the wild-type (WT) cells to examine how far Pol zeta L2618M extends the primer DNA after bypassing the lesion. The adduct induced primarily G to T and G to C at the adducted site in both cell lines, but generated additional sequence changes such as base substitutions, deletions and additions in the extension patch much more often in REV3 L2618M cells than in the WT cells. Mutations in the extension patch in REV3 L2618M cells occurred most often within 10 bps from the adducted site. Then, the number of mutations gradually decreased and no mutations were observed between 30 and 40 bps from the lesion. We concluded that human Pol zeta L2618M and perhaps WT Pol extend the primer DNA up to approximately 30 bps from the lesion in vivo. The possibility of involvement of Pol zeta L2618M in the insertion step of TLS is discussed.